Target intelligence / Profile preview

Adhesion G protein-coupled receptor A3 (ADGRA3)

Target
ADGRA3
Molecular classification
G protein-coupled receptor, Adhesion G protein-coupled receptor, Receptor
01

Overview

Adhesion G protein-coupled receptor A3 (ADGRA3), previously known as GPR125, is a member of the adhesion class of G protein-coupled receptors (GPCRs) characterized by long N-terminal extracellular regions with protein-protein interaction motifs such as Ig-like domains and leucine-rich repeats. ADGRA3 is classified as an orphan receptor since no endogenous ligands have been identified to date. It is highly expressed in the testis and prostate, with evidence suggesting a role in the development of spermatogonia and germ cell function. The receptor has also been implicated as a marker for adult stem and progenitor cells, and its expression is upregulated following brain injury, suggesting possible wider roles in tissue homeostasis and repair. However, direct biological functions and disease associations remain only partially defined, and it is not yet a target for approved therapeutics[1].

Other names
GPR125PGR21TEM5LG protein-coupled receptor 125TEM5-likeUNQ556/PRO1113FLJ38547probable G-protein coupled receptor 125
02

Mechanism of action

Not established (as no known ligands or drugs targeting ADGRA3)

03

Biological functions

Signal transductionCell adhesionStem/progenitor cell markerPossible role in spermatogonia and germ cell development
04

Disease associations

Potential role in cancer (tumor angiogenesis and proliferation)Possible involvement in reproductive disordersReported expression/role in brain injury models
05

Safety considerations

None reported (therapeutic use and drug targeting are still unexplored due to orphan status; potential effects on stem cell populations should be considered as a theoretical concern)
06

Interacting drugs

None known (no endogenous or exogenous ligands identified; orphan receptor)
07

Biomarkers

Marker for adult stem and progenitor cells, particularly spermatogonial stem cells

Beyond the preview

Go deeper on Adhesion G protein-coupled receptor A3 (ADGRA3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adhesion G protein-coupled receptor A3 (ADGRA3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call